Voisard Asset Management Group, Inc. Biomarin Pharmaceutical Inc Transaction History
Voisard Asset Management Group, Inc.
- $240 Billion
- Q3 2024
A detailed history of Voisard Asset Management Group, Inc. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Voisard Asset Management Group, Inc. holds 1,355 shares of BMRN stock, worth $87,072. This represents 0.04% of its overall portfolio holdings.
Number of Shares
1,355
Previous 1,150
17.83%
Holding current value
$87,072
Previous $94.7 Million
0.59%
% of portfolio
0.04%
Previous 0.05%
Shares
3 transactions
Others Institutions Holding BMRN
# of Institutions
636Shares Held
178MCall Options Held
2.01MPut Options Held
1.28M-
Black Rock Inc. New York, NY22.7MShares$1.46 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.3MShares$1.24 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA18.9MShares$1.21 Billion0.99% of portfolio
-
Dodge & Cox San Francisco, CA13.9MShares$893 Million0.59% of portfolio
-
Capital Research Global Investors Los Angeles, CA10.5MShares$674 Million0.16% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $11.9B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...